Achieve Life Sciences Inc (NASDAQ: ACHV) is -10.80% lower on its value in year-to-date trading and has touched a low of $1.84 and a high of $5.31 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ACHV stock was last observed hovering at around $2.98 in the last trading session, with the day’s gains setting it 0.16%.
Currently trading at $3.14, the stock is -8.30% and 10.64% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing 5.37% at the moment leaves the stock -13.13% off its SMA200. ACHV registered -35.92% loss for a year compared to 6-month loss of -23.41%.
The stock witnessed a -5.14% gain in the last 1 month and extending the period to 3 months gives it a 17.60%, and is -12.04% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.55% over the week and 5.83% over the month.
Achieve Life Sciences Inc (ACHV) has around 25 employees, a market worth around $108.91M and $0.00M in sales. Distance from 52-week low is 70.65% and -40.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-243.10%).
The EPS is expected to shrink by -4.84% this year
The shares outstanding are 34.69M, and float is at 29.37M with Short Float at 8.93%.
The top institutional shareholder in the company is FRANKLIN RESOURCES INC with over 6.05 million shares valued at $19.6 million. The investor’s holdings represent 17.6358 of the ACHV Shares outstanding. As of 2024-06-30, the second largest holder is PROPEL BIO MANAGEMENT, LLC with 2.45 million shares valued at $11.53 million to account for 7.148 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 1.96 million shares representing 5.701 and valued at over $9.2 million, while VANGUARD GROUP INC holds 4.3875 of the shares totaling 1.51 million with a market value of $7.08 million.
Achieve Life Sciences Inc (ACHV) Insider Activity
The most recent transaction is an insider purchase by Oki Mark K, the company’s Chief Financial Officer. SEC filings show that Oki Mark K bought 10,000 shares of the company’s common stock on Mar 17 ’25 at a price of $2.89 per share for a total of $28887.0. Following the purchase, the insider now owns 10000.0 shares.
Achieve Life Sciences Inc disclosed in a document filed with the SEC on Mar 17 ’25 that Stewart Richard Alistair (Chieve Executive Officer) bought a total of 10,000 shares of the company’s common stock. The trade occurred on Mar 17 ’25 and was made at $2.86 per share for $28598.0. Following the transaction, the insider now directly holds 60876.0 shares of the ACHV stock.
